20405 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines Morphinan derivatives, e.g. morphine, codeine
Opioid receptor antagonist prodrugs
#1202Methods for treating antipsychotic-induced weight gain
#1203Acetate salt of buprenorphine and methods for preparing buprenorphine
#1204Methods of providing weight loss therapy in patients with major depression
#1205EV-MEDIATED DELIVERY OF BINDING PROTEIN-SMALL MOLECULE CONJUGATES
#1206Stable oral solutions for combined API
#1207Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same
#1208EXTENDED RELEASE DRUG FORMULATION WITH OVERDOSE PROTECTION AND ABUSE DETERRENCE
#1209ABUSE-PROOFED DOSAGE FORM
#1210Methods For Administering Weight Loss Medications
#1211Compositions and methods for reducing overdose
#1212PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSION, ANXIETY, AND NEURODEGENERATIVE DISORDERS
#1213METHODS OF SAFELY TRANSITIONING A SUBJECT TO BUPRENORPHINE
#1214INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
#1215Intranasal epinephrine formulations and methods for the treatment of disease
#1216INTRANASAL EPINEPHRINE FORMULATIONS AND METHODS FOR THE TREATMENT OF DISEASE
#1217Tamper-resistant tablet providing immediate drug release
#1218Tamper-resistant pharmaceutical compositions of opioids and other drugs
#1219Pharmaceutical resinate compositions and methods of making and using thereof
#1220SUSTAINED RELEASE BUPRENORPHINE MICROSPHERES (SRBM) AND METHODS OF USE THEREOF
#1221PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#1222Solid preparation having improved light stability
#1223COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF OPIOID-RECEPTOR-MEDIATED CONDITIONS
#1224PHARMACEUTICALLY ACCEPTABLE SALTS AND POLYMORPHIC FORMS OF HYDROCODONE BENZOIC ACID ENOL ESTER AND PROCESSES FOR MAKING SAME
#1225Method for administering omega-conopeptide
#1226Process of making stable abuse-deterrent oral formulations
#1227Methods and Compositions for Treating Vasomotor Symptoms
#1228COMPOUND AND METHOD FOR REDUCING NEUROPATHIC PAIN AND DEPRESSION
#1229OLIGOMER-OPIOID AGONIST CONJUGATES
#1230Compositions of buprenorphine and μ antagonists
#1231Tamper resistant pharmaceutical formulations
#1232ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
#1233Methods of diagnosing endometriosis
#1234Compositions And Methods For Increasing Insulin Sensitivity
#1235TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT
#1236METHODS FOR TREATMENT AND PREVENTION OF OPIOID INDUCED CONSTIPATION USING ORAL COMPOSITIONS OF METHYLNALTREXONE
#1237Combination treatments for opioid crisis
#1238TRANSDERMAL DRUG DELIVERY DEVICE FOR DELIVERING OPIOIDS
#1239Oral Pharmaceutical Dosage Forms
#1240Non-extractable oral solid dosage forms
#1241PHARMACEUTICAL COMPOSITIONS COMPRISING HYDROMORPHONE AND NALOXONE
#1242Morphan and morphinan analogues, and methods of use
#1243Combinations of opioid/TLR4 antagonists and acetaminophen for use in the treatment of emotional pain and insomnia
#1244DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION
#1245DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION
#1246Compositions for affecting weight loss
#1247Bupropion as a modulator of drug activity
#1248Buprenorphine-wafer for drug substitution therapy
#1249Anti-CGRP compositions and use thereof
#1250TWO-COMPONENT PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PAIN
#1251ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER
#1252Sublingual opioid formulations containing naloxone
#1253Extruded immediate release abuse deterrent pill
#1254PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING
#1255COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL USE DISORDER
#1256PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#1257LONG ACTING OPIOID ANTAGONISTS
#1258Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
#1259BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#1260BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#1261TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE
#1262Opioid agonist antagonist combinations
#1263Bupropion as a modulator of drug activity
#1264Responsive elastic polymers and methods of making and using same
#1265Compositions and methods thereof
#1266Polysubunit opioid prodrugs resistant to overdose and abuse
#1267Sustained Release Formulation Of Naltrexone
#1268Cancer therapy
#1269Patch preparations with accidental use prevention features
#1270Composition and method for inhibiting platelet aggregation
#1271Naloxone Transdermal Delivery Devices and Methods for Using the Same
#1272Packaging system for oxygen-sensitive drugs
#1273Methods for treating depressive symptoms
#1274MORPHINE FORMULATIONS
#1275Polymorphic forms of naltrexone
#1276Abuse resistant pharmaceutical compositions
#1277TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#1278ARYLFLUOROSULFATE COMPOUNDS AND METHODS
#1279Tamper resistant pharmaceutical formulations
#1280Micronized Opioid Compositions, Formulations and Dosage Forms and Methods of Making Same
#1281Process for preparing oxycodone compositions
#1282Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
#1283Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester
#1284MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES
#1285COMBINATION OF BREXPIPRAZOLE AND NALMEFENE AND USE THEREOF FOR TREATING SUBSTANCE-RELATED DISORDERS
#1286TREATMENT OF ALCOHOLISM AND DEPRESSION AND/OR DYSPHORIC MOOD USING IBUDILAST
#1287Transdermal delivery of high viscosity bioactive agents
#1288Modified release formulations containing drug-ion exchange resin complexes
#1289Sustained-release buprenorphine formulations
#1290THERAPEUTIC FORMULATIONS AND USES THEREOF
#1291Bupropion as a modulator of drug activity
#1292TAMPER-RESISTANT DOSAGE FORM CONTAINING ONE OR MORE PARTICLES
#1293Pharmaceutical compositions and methods
#1294Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#1295Method of Restoring the Incretin Effect
#1296Immediate release abuse-deterrent granulated dosage forms
#1297Drug delivery device and method
#1298Therapeutic compositions and methods with cytokine signaling immunomodulators
#1299Compositions comprising substituted benzofuroquinolizine and psychoactive drug
#13008-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
#1301Permeant delivery system and methods for use thereof
#1302Immediate release abuse deterrent formulations
#1303Oral formulations and lipophilic salts of methylnaltrexone
#1304Oral formulations and lipophilic salts of methylnaltrexone
#1305PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN
#1306A DEVICE FOR THE TRANSDERMAL DELIVERY OF BUPRENORPHINE
#1307Pharmaceutical formulation containing gelling agent
#1308Sustained release formulations of nalbuphine
#1309Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof
#1310ABUSE-RESISTANT CONTROLLED-RELEASE OPIOID DOSAGE FORM
#1311TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#1312Pain Medicine Combination and Uses Thereof
#1313TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE
#1314PHARMACEUTICAL COMPOSITIONS COMPRISING A DEXTROMETHORPHAN COMPOUND AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA
#1315Pharmaceutical Formulation Containing Gelling Agent
#1316MODIFIED RELEASE ABUSE DETERRENT DOSAGE FORMS
#1317Drug depots for treatment of pain and inflammation
#1318METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS
#1319BIODEGRADABLE DRUG DELIVERY COMPOSITIONS
#1320ABUSE RESISTANT DRUG FORMULATION
#1321METHODS FOR TREATING PRURITUS
#1322Analgesic compositions
#1323COMPOSITIONS AND METHODS FOR TREATING OPIOID RECEPTOR ASSOCIATED DISEASES
#1324SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT
#1325Chemically modified small molecules
#1326Compositions and methods to promote bone formation and their uses including for the treatment of cancer
#1327Anti-CGRP compositions and use thereof
#1328Multifunctional aminoquinoline therapeutic agent
#1329CROSSLINKED POLYMER NANO-ASSEMBLIES AND USES THEREOF
#1330COMPOSITIONS AND METHODS FOR MINIMIZING OR REVERSING AGONIST-INDUCED DESENSITIZATION
#1331Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1332Anti-inflammatory pharmaceutical compositions and methods of administration
#1333Biguanide compositions and methods of treating metabolic disorders
#1334ABUSE AND MISUSE DETERRENT TRANSDERMAL SYSTEMS
#1335Process for making controlled release medical implant and non-implant products
#1336APPARATUS AND METHODS FOR RAPID TRANSMUCOSAL DRUG DELIVERY
#1337ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS
#1338Compositions and methods for immune-mediated cancer therapy
#1339METHOD OF SELECTIVELY INHIBITING MPGES-1
#1340Pharmaceutical formulation containing gelling agent
#1341Liquid naloxone spray
#1342Sublingual and buccal film compositions
#1343HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS
#1344MEDICAMENT DELIVERY DEVICE FOR ADMINISTRATION OF OPIOID ANTAGONISTS INCLUDING FORMULATIONS FOR NALOXONE
#1345Abuse-deterrent pharmaceutical composition
#1346Abuse-deterrent pharmaceutical compositions
#1347ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#1348TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#1349Abuse-resistant pharmaceutical composition for the treatment of opioid dependence
#1350ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
#1351OVERDOSE PROTECTION AND ABUSE DETERRENT IMMEDIATE RELEASE DRUG FORMULATION
#1352METHOD FOR CATALYTIC PREPARATION OF HYDROMORPHONE, HYDROCODONE, AND OTHER OPIATES
#1353Carboxylic diarylthiazepineamines as mu-opioid receptor agonists
#1354DEVICES FOR EVAPORATION AND INHALATION OF NICOTINE
#1355Oligomer-opioid agonist conjugates
#1356PHARMACEUTICAL FORMULATION CONTAINING IRRITANT
#1357Abuse-Resistant Drug Formulations
#1358COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION
#1359Preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives
#1360Vaporized medicants and methods of use
#1361Morphinan compounds
#1362SUBLINGUAL AND BUCCAL FILM COMPOSITIONS
#1363Devices for evaporation and inhalation of active agents
#1364Method for performing cosmetic surgical procedures using tumescent anesthesia and oral sedation
#1365Combined herbal and pharmaceutical composition and method
#1366ABUSE-PROOFED DOSAGE FORM
#1367Sulfur(VI) fluoride compounds and methods for the preparation thereof
#1368CONTROLLED RELEASE HYDROCODONE FORMULATIONS
#1369Sustained-release buprenorphine solutions
#1370Compositions and methods for prophylaxis and treatment of addictions
#1371TRANSDERMAL PATCH
#1372TRANSDERMAL PATCH
#1373TRPA1 modulators
#1374REGULATION OF GENE EXPRESSION BY MODULATING PRIMARY CILIA LENGTH
#1375Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan
#1376Treatments and prevention of opioid neonatal abstinence syndrome
#1377Pharmaceutical Formulation Containing Gelling Agent
#1378NASAL DRUG PRODUCTS AND METHODS OF THEIR USE
#13791-ARYL-3-AMINOALKOXY PYRAZOLES AS SIGMA LIGANDS ENHANCING ANALGESIC EFFECT OF OPIOIDS AND ATTENUATING THE DEPENDENCY THEREOF
#1380Compositions and kits useful for treatment of respiratory illness
#1381METHOD OF TREATING SCHIZOPHRENIA
#1382ABUSE-PROOFED DOSAGE FORM
#1383IDENTIFICATION OF ADDITIONAL ANTI-PERSISTER ACTIVITY AGAINST BORRELIA BURGDORFERI FROM AN FDA DRUG LIBRARY
#1384BUPROPION AND DEXTROMETHORPHAN FOR TREATING NICOTINE ADDICTION
#1385Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1386Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1387Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
#1388BUPROPION AS A MODULATOR OF DRUG ACTIVITY
#1389INJECTABLE COMPOSITION AND A METHOD OF TREATMENT OF THE PHYSICAL ADDICTION
#1390ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
#1391OPIOID RECEPTOR BLOCKADE IN TREATING ALCOHOL USE DISORDERS
#1392Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#1393TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#1394CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS
#1395MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE
#1396Nalfurafine-containing percutaneous absorption patch
#1397Tamper-resistant tablet providing immediate drug release
#1398ABUSE DETERRENT PHARMACEUTICAL DOSAGE FORMS
#1399Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1400INTRANASAL NALOXONE COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#1401Methods to treat opioid use disorder
#1402Therapeutic approaches for treating CMT and related disorders
#1403Compositions and methods useful for treatment of respiratory illness
#1404Compositions And Methods Useful For Treatment Of Respiratory Illness
#1405Compositions And Methods Useful For Treatment Of Respiratory Illness
#1406Compositions and methods useful for treatment of respiratory illness
#1407Methods for administering weight loss medications
#1408BIPHASIX CANNABINOID DELIVERY
#1409CONTROLLED RELEASE HYDROCODONE FORMULATIONS
#1410Use of amisulpride as an anti-emetic
#1411Analgesic preparation with nanocarriers and use thereof
#1412PHARMACEUTICAL COMPOSITIONS
#1413COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY
#1414ABUSE RESISTANT TRANSDERMAL DELIVERY DEVICES AND COMPOSITIONS COMPRISING AN OPIOID AGONIST AND A NON-TRANSDERMALLY DELIVERED N-OXIDE DERIVATIVE OF AN OPIOID ANTAGONIST FOR THE TREATMENT OF PAIN
#1415Anise flavored medication
#1416Anti-overingestion abuse deterrent compositions
#1417Long-acting non-aqueous injectable formulations and use thereof
#1418Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
#1419Compositions with a rheological modifier to reduce dissolution variability
#1420Therapeutic approaches for treating CMT and related disorders
#1421Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof
#1422OXYMORPHONE CONTROLLED RELEASE COMPOSITIONS
#1423Treating pain in patients with hepatic impairment
#1424Compositions and methods useful for treatment of respiratory illness
#1425Implantable Naltrexone tablets
#1426Antihistamine compositions, combinations, and use thereof
#1427PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN
#1428Methods Of Safely Transitioning A Subject To Buprenorphine
#1429Pharmaceutical compositions for treating or preventing pain
#1430Morphinan Compounds
#1431PHARMACEUTICAL COMPOSITIONS
#1432Base Composition for Tape Agent
#1433USE OF NALMEFENE IN NON-ALCOHOLIC STEATOHEPATITIS
#1434TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT
#1435Glutamate agents in the treatment of mental disorders
#1436Drug delivery composition containing silyl polymers
#1437Abuse-proofed dosage form
#1438FILM COMPOSITIONS OF SAMIDORPHAN AND BUPRENORPHINE
#1439Pharmaceutical combination of opioid and prostaglandin compound
#1440Method for inhibiting growth of cancer cells
#1441LIPID DEPOT FORMULATIONS
#1442Morphinan derivative and medical usage thereof
#1443Compositions comprising apomorphine and organic acids and uses thereof
#1444Transdermal dosage form
#1445ABUSE RESISTANT DRUG FORMULATION
#1446Polymorphic forms of naltrexone
#1447Compositions for deterring abuse of pharmaceutical products and alcohol
#1448UNIT ORAL SOLID DOSE COMPOSITIONS COMPOSED OF IBUPROFEN AND NIZATIDINE
#1449Intravenous administration of tramadol
#1450ENHANCED ABUSE-DETERRENT FORMULATIONS OF OXYCODONE
#1451Process for making controlled release medical implant products
#1452MAPC treatment of brain injuries and diseases
#1453Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
#1454Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
#1455UNIFORM FILMS FOR RAPID-DISSOLVE DOSAGE FORM INCORPORATING ANTI-TACKING COMPOSITIONS
#1456FOOD INDEPENDENT IMMEDIATE RELEASE DRUG FORMULATION WITH ABUSE DETERRENCE AND OVERDOSE PROTECTION
#1457Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
#1458Sublingual apomorphine
#1459TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING THE ACTIVE SUBSTANCE BUPRENORPHINE
#1460Process of making stable abuse-deterrent oral formulations
#1461Oral Drug Delivery System
#1462Treatment of addiction and impulse-control disorders using PDE7 inhibitors
#1463Patch preparation containing an acid scavenger
#1464CANNABINOID RECEPTOR MODULATORS
#1465Combination of opioids and anticancer drugs for cancer treatment
#1466Adhesive polymer and medical adhesive patch
#1467IMMEDIATE RELEASE, ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS
#1468METAP2 inhibitors and methods of treating obesity
#1469Methods for treating antipsychotic-induced weight gain
#1470Packaged multi-dose liquid dextromethorphan hydrobromide formulation
#1471Filter precleaner
#1472Use of creatine kinase and derived peptides thereof to relieve pain
#1473THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE
#1474Crystalline salts of naloxone and naltrexone
#1475Cocrystals of naloxone and naltrexone
#1476Oral particulate composition
#1477Syringe assembly
#1478Oligomer-opioid agonist conjugates
#1479Transdermal Delivery System
#1480Reduced dose intravenous acetaminophen
#1481Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#1482CONTROLLED-RELEASE FORMULATIONS
#1483IMMEDIATE RELEASE, ABUSE DETERRENT PHARMACEUTICAL COMPOSITIONS
#1484Compositions for treating CMT and related disorders
#1485Therapeutic approaches for treating CMT and related disorders
#1486Novel Alpha-Hydroxy Carboxylic Acid And Derivatives And Other GRAS-Based Prodrugs Of Oxymorphone And Uses Thereof
#1487ABUSE DETERRENT OPIOID FORMULATIONS
#1488OPIOID FORMULATIONS
#1489Lymph directing prodrugs
#1490SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS
#1491DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
#1492MORPHINAN COMPOUNDS FOR TREATING AGITATION
#1493DEUTERATED MORPHINAN COMPOUNDS FOR TREATING AGITATION
#1494Compositions and methods for weight loss in at risk patient populations
#1495ABUSE-PROOFED DOSAGE FORM
#1496Therapeutic compounds
#1497Percutaneous absorption composition
#1498Compositions with a Rheological Modifier to Reduce Dissolution Variability
#1499Pancreatitis treatment
#1500Acetate salt of buprenorphine and methods for preparing buprenorphine